← Back to headlines
Novo Nordisk's Wegovy Pill Faces Crucial Production Test
Novo Nordisk is making a significant push for its Wegovy pill, which has been a strong competitor against Eli Lilly. However, following a supply crisis in 2021, analysts are questioning whether production can keep pace with the high demand.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
